That's great. Problem is it's main competitor WEED, Canopy, has better footing in the market and more name recognition. CMED way overvalued and market cap ridiculously high. Also Aurora paid a premium for this one. A terribly bad move. May work out in the end but for now it can't sustain these prices. Below $30 again next week. GL